Management of osteoarthritis in the context of COVID-19

Authors

  • Vadym Sulyma Ivano-Frankivsk National Medical University. Ukraine, Ukraine
  • Yuliia Filiak Ivano-Frankivsk National Medical University. Ukraine, Ukraine
  • Vitalii Voronych Ivano-Frankivsk National Medical University. Ukraine, Ukraine

DOI:

https://doi.org/10.15674/0030-598720221-262-70

Keywords:

pandemic, COVID-19

Abstract

Regular revision of the management of osteoarthritis by world associations has been performing both to the epidemiological
features of the spread of the disease in 80% of the after-50-years-old population, and to the comorbidities. The group
of this age has the highest risk of susceptibility and severe course of COVID–19. Objective. To reveal the features of the step-bystep algorithm for the treatment of patients with osteoarthritis in the conditions of the COVID-19 pandemic. Methods. The study is based on the analysis of the published data on the peculiarities of non-pharmacological and pharmacological means according to the step-by-step algorithm for the treatment of patients with osteoarthritis. 227 published scientific sources, from which 54 editions with a reliable evidence base were selected. Results. The treatment of patients with osteoarthritis in the conditions of a pandemic requires correction, due to the use of drugs with certain pharmacokinetic and pharmacodynamic properties that can atypically or negatively affect the systems of the body. Each of the four steps of the treatment algorithms for patients with osteoarthritis was analyzed, taking into account the pathophysiological features of the course of chronic joint disease and acute viral damage to the respiratory system. It was noted that despite the high variability of treatment methods for patients with osteoarthritis, decisions regarding the therapeutic tactic should be made taking into consideration the individual characteristics of the body and comorbidities. It was emphasized that the final decision regarding the prescription of corticosteroids and non-steroidal anti-inflammatory drugs must be properly argumented. The correction of the treatment measures set at each step of the algorithm is proposed. It would prevent the aggravation of the chronic impression of the joints in the adverse situation of the COVID-19 pandemic. Conclusions. A profound search in the scientific published sources for evidence concerning the specifics of the effect of non-pharmacological and pharmacological means of treatment for patients with osteoarthritis will allow to use their effects effectively using step-by-step algorithm especially during the dangerous pandemic situation.

Author Biographies

Vadym Sulyma, Ivano-Frankivsk National Medical University. Ukraine

MD, Prof. in Traumatology and Orthopaedics

Yuliia Filiak, Ivano-Frankivsk National Medical University. Ukraine

MD, PhD in Traumatology and Orthopaedics

Vitalii Voronych, Ivano-Frankivsk National Medical University. Ukraine

MD

References

  1. Ragni, E., Mangiavini, L., Viganò, M., Brini, A. T., Peretti, G. M., Banfi, G., & Girolamo, L. (2020). Management of osteoarthritis during the COVID‐19 pandemic. Clinical Pharmacology & Therapeutics, 108(4), 719-729. doi:10.1002/cpt.1910
  2. Soroka, М.F. (2020). Osteoarthritis and comorbidity: features of treatment of patients at the present stage. Ukrainian Journal of Rheumatology, 2 (80), 77‒87. doi: 10.32471/rheumatology.2707-6970.80.15122.
  3. Endstrasser, F., Braito, M., Linser, M., Spicher, A., Wagner, M., & Brunner, A. (2020). The negative impact of the COVID-19 lockdown on pain and physical function in patients with end-stage hip or knee osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy, 28(8), 2435-2443. doi:10.1007/s00167-020-06104-3.
  4. Bruyère, O., Honvo, G., Veronese, N., Arden, N. K., Branco, J., Curtis, E. M., … Reginster, J. (2019). An updated algorithm recommendation for the management of knee osteoarthritis from the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Seminars in Arthritis and Rheumatism, 49(3), 337-350. doi:10.1016/j.semarthrit.2019.04.008
  5. Verduzco‐Gutierrez, M., Bean, A. C., Tenforde, A. S., Tapia, R. N., & Silver, J. K. (2020). How to conduct an outpatient telemedicine rehabilitation or Prehabilitation visit. PM&R, 12(7), 714-720. doi:10.1002/pmrj.12380
  6. The centre for evidence-based medicine. (2020, November 25). Retrieved from https://www.cebm.net/covid-19/maximising-mobilityin-the-older-people-when-isolated-with-covid-19/
  7. Chtourou, H., Trabelsi, K., H'mida, C., Boukhris, O., Glenn, J. M., Brach, M., … Bragazzi, N. L. (2020). Staying physically active during the quarantine and self-isolation period for controlling and mitigating the COVID-19 pandemic: A systematic overview of the literature. Frontiers in Psychology, 11. doi:10.3389/fpsyg.2020.01708
  8. Food and nutrition during self-quarantine: what to choose and how to eat healthily (2020). WHO. Retrieved from: https://www.euro.who.int/en/health-topics/disease-prevention/nutrition/news/news/2020/3/food-andnutrition-during-self-quarantine-what-to-choose-and-howto-eat-healthily
  9. Safe aquatic physiotherapy practice in relation to the COVID-19 pandemic. Retrieved from: https:// www.pwtag.org/safe-aquatic-physiotherapy-practice-duringcovid-19-guidelines/
  10. Lambert, C., Mathy-Hartert, M., Dubuc, J., Montell, E., Vergés, J., Munaut, C., … Henrotin, Y. (2012). Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate. Arthritis Research & Therapy, 14(2), R58. doi:10.1186/ar3771
  11. Zhang, Z., Huang, C., Cao, Y., Mu, R., Zhang, M. C., Xing, D., … Zhang, H. (2021). 2021 revised algorithm for the management of knee osteoarthritis—the Chinese viewpoint. Aging Clinical and Experimental Research, 33(8), 2141-2147. doi:10.1007/s40520-021-01906-y
  12. Yu, C., Zang, H., Yang, C., Liang, D., Quan, S., Li, D., … Li, L. (2021). Study of chondroitin sulfate E oligosaccharide as a promising complement C5 inhibitor for osteoarthritis alleviation. Materials Science and Engineering: C, 127, 112234. doi:10.1016/j.msec.2021.112234
  13. De Oliveira, P. G., Termini, L., Durigon, E. L., Lepique, A. P., Sposito, A. C., & Boccardo, E. (2020). Diacerein: A potential multi-target therapeutic drug for COVID-19. Medical Hypotheses, 144, 109920. doi:10.1016/j.mehy.2020.109920
  14. Kingsbury, S. R., Gross, H. J., Isherwood, G., & Conaghan, P. G. (2014). Osteoarthritis in Europe: Impact on health status, work productivity and use of pharmacotherapies in five European countries. Rheumatology, 53 (5), 937-947. doi:10.1093/rheumatology/ket463
  15. Conaghan, P. G., Arden, N., Avouac, B., Migliore, A., & Rizzoli, R. (2019). Safety of paracetamol in osteoarthritis: What does the literature say? Drugs & Aging, 36(S1), 7-14. doi:10.1007/s40266-019-00658-9
  16. Zhang, C., Shi, L., Wang, F. S. (2020). Liver injury in COVID-19: management and challenges. The Lancet. Gastroenterology & hepatology, 5 (5), 428–430. doi: 10.1016/S2468-1253(20)30057-1.
  17. Li, S., Yue, J., Dong, B. R., Yang, M., Lin, X., & Wu, T. (2013). Acetaminophen (paracetamol) for the common cold in adults. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd008800.pub2
  18. Chandan, J, Zemedikun, D, Thayakaran, R, Byrne, N, Dhalla , S, Acosta-Mena , D, Gokhale, K, Thomas, T, Sainsbury, C, Subramanian, A, Cooper, J, Anand, A, Okoth, K, Wang, J, Adderley, N, Taverner, T, Denniston, A, Lord, J, Thomas, GN, Buckley, C, Raza, K, Bhala, N, Nirantharakumar, K & Haroon, S 2021, 'Nonsteroidal antiinflammatory drugs and susceptibility to COVID19', Arthritis and Rheumatology, 73, 5, 731-739. https://doi.org/10.1002/art.41593
  19. Gore, M., Tai, K., Sadosky, A., Leslie, D., & Stacey, B. R. (2012). Use and costs of prescription medications and alternative treatments in patients with osteoarthritis and chronic low back pain in community-based settings. Pain Practice, 12 (7), 550-560. doi:10.1111/j.1533-2500.2012.00532.x
  20. Smith, S., Deshpande, B., Collins, J., Katz, J., & Losina, E. (2016). Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: Systematic analytic review. Osteoarthritis and Cartilage, 24 (6), 962-972. doi:10.1016/j.joca.2016.01.135
  21. Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., … Xu, G. (2020). Kidney impairment is associated with in-hospital death of COVID-19 patients. Kidney International 97 (5), 829–838. doi: 10.1016/j.kint.2020.03.005
  22. Voiriot, G., Philippot, Q., Elabbadi, A., Elbim, C., Chalumeau, M., & Fartoukh, M. (2019). Risks related to the use of non-steroidal anti-inflammatory drugs in community-acquired pneumonia in adult and pediatric patients. Journal of Clinical Medicine, 8(6), 786. doi:10.3390/jcm8060786
  23. Varrassi, G. (2020). Warning against the use of anti-inflammatory medicines to cure COVID-19: Building castles in the air. Advances in Therapy, 37 (5), 1705-1707. doi:10.1007/s12325-020-01321-1
  24. Maheu, E., Rannou, F., & Reginster, J. (2016). Efficacy and safety of hyaluronic acid in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Seminars in Arthritis and Rheumatism, 45 (4), S28-S33. doi:10.1016/j.semarthrit.2015.11.008
  25. Campbell, K. A., Erickson, B. J., Saltzman, B. M., Mascarenhas, R., Bach, B. R., Cole, B. J., & Verma, N. N. (2015). Is local Viscosupplementation injection clinically superior to other therapies in the treatment of osteoarthritis of the knee: A systematic review of overlapping meta-analyses. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 31 (10), 2036-2045.e14. doi:10.1016/j.arthro.2015.03.030.
  26. Altman, R., Lim, S., Steen, R. G., & Dasa, V. (2015). Hyaluronic acid injections are associated with delay of total knee replacement surgery in patients with knee osteoarthritis: Evidence from a large U.S. health claims database. PLOS ONE, 10(12), e0145776. doi:10.1371/journal.pone.0145776
  27. Castro da Rocha F. A., Melo, L., Berenbaum, F. (2021). Tackling osteoarthritis during COVID-19 pandemic. Annals of the Rheumatic Diseases, 80 (2), 151–153. doi: 10.1136/annrheumdis-2020-218372.
  28. Maheu, E., Bannuru, R. R., Herrero-Beaumont, G., Allali, F., Bard, H., & Migliore, A. (2019). Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature review. Seminars in Arthritis and Rheumatism, 48 (4), 563-572. doi:10.1016/j.semarthrit.2018.06.002
  29. Dorleijn, D. M., Luijsterburg, P. A., Reijman, M., Kloppenburg, M., Verhaar, J. A., Bindels, P. J., … Bierma-Zeinstra, S. M. (2018). Intramuscular glucocorticoid injection versus placebo injection in hip osteoarthritis: A 12-week blinded randomised controlled trial. Annals of the Rheumatic Diseases, 77 (6), 875–882. doi:10.1136/annrheumdis-2017-212628
  30. Becker, D. E. (2013). Basic and clinical pharmacology of Glucocorticosteroids. Anesthesia Progress, 60 (1), 25-32. doi:10.2344/0003-3006-60.1.25
  31. Harris, L. K., & Crannage, A. J. (2021). Corticosteroids in community-acquired pneumonia: A review of current literature. Journal of Pharmacy Technology, 37 (3), 152-160. doi:10.1177/8755122521995587
  32. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Retrieved from: https://apps.who.int/iris/bitstream/ handle/10665/331446/WHO-2019-nCoV-clinical-2020.4-rus.pdf?sequence=17&isAllowed=y
  33. Hermann, W., Lambova, S., & Müller- Ladner, U. (2018). Current treatment options for osteoarthritis. Current Rheumatology Reviews, 14(2), 108-116. doi:10.2174/1573397113666170829155149
  34. Avouac, J., Gossec, L., & Dougados, M. (2007). Efficacy and safety of opioids for osteoarthritis: A meta-analysis of randomized controlled trials. Osteoarthritis and Cartilage, 15(8), 957-965. doi:10.1016/j.joca.2007.02.006
  35. Franchi, S., Moschetti, G., Amodeo, G., & Sacerdote, P. (2019). Do all opioid drugs share the same immunomodulatory properties? A review from animal and human studies. Frontiers in Immunology, 10. doi:10.3389/fimmu.2019.02914
  36. Toupin April, K., Bisaillon, J., Welch, V., Maxwell, L. J., Jüni, P., Rutjes, A. W., … Tugwell, P. (2019). Tramadol for osteoarthritis. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd005522.pub3
  37. Dublin, S., Walker, R. L., Jackson, M. L., Nelson, J. C., Weiss, N. S., Korff, M., & Jackson, L. A. (2011). Use of opioids or benzodiazepines and risk of pneumonia in older adults: A population-based case-control study. Journal of the American Geriatrics Society, 59(10), 1899-1907. doi:10.1111/j.1532-5415.2011.03586.x
  38. Zhao, Z., Li, M., & Liu, R. (2020). Suggestions on surgical treatment during coronavirus disease 2019 (COVID-19) pandemic. BioScience Trends, 14(3), 227-230. doi:10.5582/bst.2020.03098
  39. Hohmann, E., Tetsworth, K., & Glatt, V. (2020). Is platelet-rich plasma effective for the treatment of knee osteoarthritis? A systematic review and meta-analysis of level 1 and 2 randomized controlled trials. European Journal of Orthopaedic Surgery & Traumatology, 30(6), 955-967. doi:10.1007/s00590-020-02623-4
  40. Chen, Z., Ge, Y., Zhou, L., Li, T., Yan, B., Chen, J., … Shan, L. (2021). Pain relief and cartilage repair by Nanofat against osteoarthritis: Preclinical and clinical evidence. Stem Cell Research & Therapy, 12(1). doi:10.1186/s13287-021-02538-9.
  41. Mora, J. C., Przkora, R., & Cruz-Almeida, Y. (2018). Knee osteoarthritis: Pathophysiology and current treatment modalities. Journal of Pain Research, 11, 2189-2196. doi:10.2147/jpr.s154002
  42. Alves, R., & Grimalt, R. (2018). A review of platelet-rich plasma: History, biology, mechanism of action, and classification. Skin Appendage Disorders, 4(1), 18-24. doi:10.1159/000477353.
  43. Shariatzadeh, M., Song, J., & Wilson, S. L. (2019). The efficacy of different sources of mesenchymal stem cells for the treatment of knee osteoarthritis. Cell and Tissue Research, 378(3), 399-410. doi:10.1007/s00441-019-03069-9
  44. Lee, W., Kim, H. J., Kim, K., Kim, G. B., & Jin, W. (2019). Intra-articular injection of autologous adipose tissue-derived Mesenchymal stem cells for the treatment of knee osteoarthritis: A phase IIb, randomized, placebo-controlled clinical trial. Stem Cells Translational Medicine, 8(6), 504-511. doi:10.1002/sctm.18-0122
  45. Mapp, P. I., & Walsh, D. A. (2012). Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nature Reviews Rheumatology, 8(7), 390-398. doi:10.1038/nrrheum.2012.80
  46. Driban, J. B., Harkey, M. S., Liu, S., Salzler, M., & McAlindon, T. E. (2020). Osteoarthritis and aging: Young adults with osteoarthritis. Current Epidemiology Reports, 7(1), 9-15. doi:10.1007/s40471-020-00224-7
  47. Landers, S., Hely, R., Page, R., Maister, N., Hely, A., Harrison, B., & Gill, S. (2020). Genicular artery Embolization to improve pain and function in early-stage knee osteoarthritis—24-Month pilot study results. Journal of Vascular and Interventional Radiology, 31(9), 1453-1458. doi:10.1016/j.jvir.2020.05.007
  48. Torkian, P., Golzarian, J., Chalian, M., Clayton, A., Rahimi-Dehgolan, S., Tabibian, E., & Talaie, R. (2021). Osteoarthritis-related knee pain treated with Genicular artery Embolization: A systematic review and meta-analysis. Orthopaedic Journal of Sports Medicine, 9(7), 232596712110213. doi:10.1177/23259671211021356
  49. Maani, A., Oli, B., Elsayed, H., Nassasra, A. (2020). Osteoarthritis of the knee: Recent advances and management during COVID-19 era. American Journal of Biomedical Science & Research, 11(1), 105-111. doi:10.34297/ajbsr.2020.11.001597
  50. Fangel, R., Vendrusculo-Fangel, L. M., Albuquerque, C. P., Parizotto, N. A., Paz, C. C., & Matheus, J. P. (2019). Low level laser therapy for reducing pain in rheumatoid arthritis and osteoarthritis: A systematic review. Fisioterapia em Movimento, 32. doi:10.1590/1980-5918.032.ao29
  51. Cherian, J. J., Kapadia, B. H., McElroy, M. J., Johnson, A. J., Bhave, A., Harwin, S. F., & Mont, M. A. (2016). Knee osteoarthritis: Does transcutaneous electrical nerve stimulation work? Orthopedics, 39(1). doi:10.3928/01477447-20151222-02
  52. Shimoura, K., Iijima, H., Suzuki, Y., & Aoyama, T. (2019). Immediate effects of transcutaneous electrical nerve stimulation on pain and physical performance in individuals with Preradiographic knee osteoarthritis: A randomized controlled trial. Archives of Physical Medicine and Rehabilitation, 100(2), 300-306.e1. doi:10.1016/j.apmr.2018.08.189
  53. French, H. P., Fitzpatrick, M., & FitzGerald, O. (2011). Responsiveness of physical function outcomes following physiotherapy intervention for osteoarthritis of the knee: An outcome comparison study. Physiotherapy, 97(4), 302-308. doi:10.1016/j.physio.2010.03.002
  54. McAlindon, T., Bannuru, R., Sullivan, M., Arden, N., Berenbaum, F., Bierma-Zeinstra, S., … Underwood, M. (2014). OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis and Cartilage, 22(3), 363-388. doi:10.1016/j.joca.2014.01.003.

Downloads

How to Cite

Sulyma, V. ., Filiak, Y. ., & Voronych, V. . (2023). Management of osteoarthritis in the context of COVID-19. ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS, (1-2), 62–70. https://doi.org/10.15674/0030-598720221-262-70

Issue

No. 1-2 (2022)

Section

ORIGINAL ARTICLES

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The authors retain the right of authorship of their manuscript and pass the journal the right of the first publication of this article, which automatically become available from the date of publication under the terms of Creative Commons Attribution License, which allows others to freely distribute the published manuscript with mandatory linking to authors of the original research and the first publication of this one in this journal.

Authors have the right to enter into a separate supplemental agreement on the additional non-exclusive distribution of manuscript in the form in which it was published by the journal (i.e. to put work in electronic storage of an institution or publish as a part of the book) while maintaining the reference to the first publication of the manuscript in this journal.

The editorial policy of the journal allows authors and encourages manuscript accommodation online (i.e. in storage of an institution or on the personal websites) as before submission of the manuscript to the editorial office, and during its editorial processing because it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the published manuscript citation (see The Effect of Open Access).